UBS Group’s Function(x) Inc. FNCX Stock Holding History

UBS Group’s Portfolio FNCX Stock Details FNCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-11,610	Closed	-$7K	–	8328
2017 Q1	$7K	Buy	+11,610	New	+$18.2K	﹤0.01%	6866
2016 Q4	–	Sell	-1,669	Closed	-$9K	–	8321
2016 Q3	$9K	Buy	1,669 +1,060	+174%	+$6K	﹤0.01%	6880
2016 Q2	$3K	Buy	609 +538	+758%	+$3.48K	﹤0.01%	7382
2016 Q1	$0	Sell	71 -141	-67%	-$974	﹤0.01%	8591
2015 Q4	$1K	Buy	212 +161	+316%	+$2.04K	﹤0.01%	8230
2015 Q3	$1K	Buy	51 +46	+920%	+$1.37K	﹤0.01%	8299
2015 Q2	$0	Sell	5 -47	-90%	-$2.15K	﹤0.01%	9119
2015 Q1	$1K	Sell	52 -46	-47%	-$1.92K	﹤0.01%	8639
2014 Q4	$5K	Buy	+98	New	+$5.92K	﹤0.01%	9042

Other funds holding FNCX

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

UBS Group's FNCX Position: Q2 2017 in Review

UBS Group sold out of Function(x) Inc. (FNCX) in Q2 2017, closing a stake of 11,610 shares — an estimated $7K sold.

UBS Group first reported a position in FNCX in Q4 2014 and held it in 9 quarters. The position peaked at $9K in Q3 2016. 3 funds tracked by Wall St. Rank hold FNCX as of Q2 2017.

UBS Group reported no remaining Function(x) Inc. position as of Q2 2017 after selling out during the quarter.
UBS Group sold 11,610 Function(x) Inc. shares in Q2 2017, an estimated $7K.
UBS Group first reported a position in Function(x) Inc. in Q4 2014 and held it in 9 quarters.
UBS Group's Function(x) Inc. position peaked at $9K in Q3 2016.
3 funds tracked by Wall St. Rank held Function(x) Inc. as of Q2 2017.

Based on UBS Group's 13F filing for Q2 2017, filed 14 Aug 2017.